BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Deguelin

a natural product from Mundulea sericea; RN refers to (7aS-cis)-isomer; structure given in first source

151+ PubMed studies analyzed · Evidence Score: 38.9

Research Domains

Deguelin has been studied across 16 research domains including 🔬 Oncology, 🔬 Inflammation, ⚡ Energy & Fatigue, ⏳ Longevity & Aging, 🫁 Liver & Detox. The primary research focus is 🔬 Oncology with 70% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Deguelin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Monocrotaline
5 shared targets
Lumefantrine
9 shared targets
Thioinosine
7 shared targets
arctigenin-4-O-(3''-O-acetyl-beta-D-glucoside)
6 shared targets
Fluvastatin
4 shared targets
casin
5 shared targets
Decitabine
6 shared targets
Polidocanol
8 shared targets
Nitrofurazone
9 shared targets
KN
5 shared targets
Loading evidence profile...

This evidence profile for Deguelin is generated deterministically from 151 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.